Sylvaine Just-Landi
Overview
Explore the profile of Sylvaine Just-Landi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
460
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bou-Tayeh B, Laletin V, Salem N, Just-Landi S, Fares J, Leblanc R, et al.
Front Immunol
. 2022 Jan;
12:730970.
PMID: 34975835
Natural Killer (NK) cells are potent anti-leukemic immune effectors. However, they display multiple defects in acute myeloid leukemia (AML) patients leading to reduced anti-tumor potential. Our limited understanding of the...
2.
Pical-Izard C, Crocchiolo R, Granjeaud S, Kochbati E, Just-Landi S, Chabannon C, et al.
Biol Blood Marrow Transplant
. 2015 Jan;
21(3):429-39.
PMID: 25579888
Recent advances in the development of reduced-intensity conditioning (RIC) have allowed a broader range of patients to access allogeneic hematopoietic stem cell transplantation (HSCT). Reconstitution of an effective immune system...
3.
Thibult M, Mamessier E, Gertner-Dardenne J, Pastor S, Just-Landi S, Xerri L, et al.
Int Immunol
. 2012 Oct;
25(2):129-37.
PMID: 23087177
The outcome of the adaptive immune response is determined by the integration of both positive and negative signals, respectively, induced upon the triggering of co-signaling receptors. One of them, programmed...
4.
Veuillen C, Aurran-Schleinitz T, Castellano R, Rey J, Mallet F, Orlanducci F, et al.
J Clin Immunol
. 2012 Feb;
32(3):632-46.
PMID: 22318393
Despite recent advances with monoclonal antibody therapy, chronic lymphocytic leukemia (CLL) remains incurable. Natural killer (NK) cells are potent antitumoral effectors, particularly against hematological malignancies. Defective recognition of B-CLL leukemic...
5.
Pasero C, Barbarat B, Just-Landi S, Bernard A, Aurran-Schleinitz T, Rey J, et al.
Eur J Immunol
. 2009 Aug;
39(9):2502-14.
PMID: 19701890
The TNF member LIGHT also known as TL4 or TNFSF14) can play a major role in cancer control via its two receptors; it induces tumor cell death through lymphotoxin-beta receptor...
6.
Fauriat C, Just-Landi S, Mallet F, Arnoulet C, Sainty D, Olive D, et al.
Blood
. 2006 Aug;
109(1):323-30.
PMID: 16940427
Natural killer (NK) cells play an important role in tumor-cell clearance, particularly against leukemia, as shown by killer cell inhibitory receptor (KIR)-mismatched allogeneic stem cell transplantation. Analysis of in vitro...